These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Italian hemodilution trial in acute stroke. Italian Acute Stroke Study Group. Stroke; 1987; 18(3):670-6. PubMed ID: 2884759 [TBL] [Abstract][Full Text] [Related]
4. [Italian Acute Stroke Study: hemodilution + drug. Presentation of the protocol]. Silvestrini M; Argentino C; Giubilei F; Sacchetti ML; Savoini G; Fieschi C Minerva Med; 1988 Aug; 79(8):695-6. PubMed ID: 3043267 [No Abstract] [Full Text] [Related]
5. Is ganglioside GM1 effective in the treatment of stroke? Braune S Drugs Aging; 1991 Jan; 1(1):57-66. PubMed ID: 1794005 [TBL] [Abstract][Full Text] [Related]
6. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. The Hemodilution in Stroke Study Group. Stroke; 1989 Mar; 20(3):317-23. PubMed ID: 2466351 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review. Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888 [TBL] [Abstract][Full Text] [Related]
8. Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). Aichner FT; Fazekas F; Brainin M; Pölz W; Mamoli B; Zeiler K Stroke; 1998 Apr; 29(4):743-9. PubMed ID: 9550505 [TBL] [Abstract][Full Text] [Related]
9. Trial of ganglioside GM1 in acute stroke. Hoffbrand BI; Bingley PJ; Oppenheimer SM; Sheldon CD J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1213-4. PubMed ID: 3066849 [TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trials of hemodilution in acute ischemic stroke. Asplund K Acta Neurol Scand Suppl; 1989; 127():22-30. PubMed ID: 2698587 [TBL] [Abstract][Full Text] [Related]
12. Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Scandinavian Stroke Study Group. Stroke; 1987; 18(4):691-9. PubMed ID: 2885946 [TBL] [Abstract][Full Text] [Related]
13. Does effect of a neuroprotective agent on volume of experimental animal cerebral infarct predict effect of the agent on clinical outcome in human stroke? Jonas S; Tran AQ; Eisenberg E; Azam M; Viera D; Grumet S Ann N Y Acad Sci; 1997 Oct; 825():281-7. PubMed ID: 9369994 [No Abstract] [Full Text] [Related]
14. Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases. Battistin L; Cesari A; Galligioni F; Marin G; Massarotti M; Paccagnella D; Pellegrini A; Testa G; Tonin P Eur Neurol; 1985; 24(5):343-51. PubMed ID: 3902480 [TBL] [Abstract][Full Text] [Related]
15. [Ganglioside GM1 in early strokes]. Kuczyńska-Zardzewiały A; Kruszewska J; Lechowicz W; Członkowska A Neurol Neurochir Pol; 1994; 28(5):643-9. PubMed ID: 7862232 [TBL] [Abstract][Full Text] [Related]
16. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside. Grieco G; d'Hollosy M; Culliford AT; Jonas S Stroke; 1996 May; 27(5):858-74. PubMed ID: 8623106 [TBL] [Abstract][Full Text] [Related]